Enabling patient specific medicines using 3D printing in hospitals and pharmacies

CurifyLabs aims to finalize a standard process for 3D printing personalized medicines using MiniLab technology, enabling scalable, high-quality customization in pharmacies.

Subsidie
€ 2.479.750
2023

Projectdetails

Introduction

Uniform drug treatments are not always the best option for treating some patient populations, including children and the elderly. The industry now has extensive knowledge on the benefits of personalized medicines that take the age, metabolic, and genetic differences of patients into account. However, until now, there has not been a practical manufacturing solution to put this knowledge into wide-scale use.

Technology Overview

CurifyLabs has created a technology called MiniLab to make high-quality 3D printing of personalized medicines available on site in pharmacies. This innovation aims to bring industry-level standards to the mass customization of medicines.

Project Goals

In this project, we will:

  1. Finalize a standard process for developing 3D printing compatible formulations.
  2. Develop quality control solutions.

These efforts will make MiniLab highly scalable across different therapeutic areas.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.479.750
Totale projectbegroting€ 3.542.500

Tijdlijn

Startdatum1-9-2023
Einddatum31-8-2025
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • CURIFYLABS OYpenvoerder

Land(en)

Finland

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

Multi-organ toxicity and efficacy test platform for Personalized medicine & Drug development

Cherry Biotech aims to revolutionize drug development and personalized medicine by providing a patented 3D cell culture platform that enhances predictability and reduces reliance on animal testing.

€ 2.499.831

Vergelijkbare projecten uit andere regelingen

Mkb-innovati...

MED-PRINT

Het project ontwikkelt een 3D-printer voor gepersonaliseerde medicatie, afgestemd op individuele patiënten, om de nauwkeurigheid en veiligheid van doseringen te verbeteren.

€ 183.750
EIC Pathfinder

Personalised Adaptive Medicine

The PERAMEDIC project aims to develop a desktop-sized system for personalized polypill formulation using 3D printing and precise dosing to enhance treatment outcomes and patient adherence.

€ 1.726.876
Mkb-innovati...

MED-MIX

Doser B.V. ontwikkelt de MED-MIX om het meng- en vulproces van MED-CARTRIDGES te automatiseren, waardoor gepersonaliseerde medicatie efficiënter en foutlozer geproduceerd kan worden.

€ 20.000
Mkb-innovati...

MED-PACK

Doser B.V. ontwikkelt MED-PRINT en MED-PACK, een innovatieve 3D-print- en verpaktechnologie voor gepersonaliseerde medicatie, die het verpakproces vereenvoudigt en fouten vermindert.

€ 20.000
1.1 - Het ve...

3D MedPrint

Het project ontwikkelt een 3D-printer voor gepersonaliseerde medicatie en test drie medicijncartridges in de praktijk.

€ 352.280